User: Guest  Login
Document type:
Journal Article; Review; Editorial Material
Author(s):
Rexer, H; Ohlmann, C-H; Gschwend, J
Title:
[First line therapy for locally advanced or metastatic urothelial cancer : A randomized double blind phase III multicenter study on adjuvant nivolumab therapy versus placebo in patients with invasive high-risk urothelial cancer (CheckMate 274)-AB 58/17 of
Journal title abbreviation:
Urologe A
Year:
2017
Journal volume:
56
Journal issue:
10
Pages contribution:
1331-1332
Language:
de
Fulltext / DOI:
doi:10.1007/s00120-017-0480-7
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/28779222
Print-ISSN:
0340-2592
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX